School of Software, Shandong University, Jinan, China; Joint SDU-NTU Centre for Artificial Intelligence Research (C-FAIR), Shandong University, Jinan, China.
Computational Biology and Bioinformatics Laboratory, Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, 16419, Gyeonggi-do, South Korea.
Comput Biol Med. 2023 Jul;161:106946. doi: 10.1016/j.compbiomed.2023.106946. Epub 2023 Apr 23.
Drug-target interactions (DTI) prediction is a crucial task in drug discovery. Existing computational methods accelerate the drug discovery in this respect. However, most of them suffer from low feature representation ability, significantly affecting the predictive performance. To address the problem, we propose a novel neural network architecture named DrugormerDTI, which uses Graph Transformer to learn both sequential and topological information through the input molecule graph and Resudual2vec to learn the underlying relation between residues from proteins. By conducting ablation experiments, we verify the importance of each part of the DrugormerDTI. We also demonstrate the good feature extraction and expression capabilities of our model via comparing the mapping results of the attention layer and molecular docking results. Experimental results show that our proposed model performs better than baseline methods on four benchmarks. We demonstrate that the introduction of Graph Transformer and the design of residue are appropriate for drug-target prediction.
药物-靶点相互作用(DTI)预测是药物发现中的一项关键任务。现有的计算方法在这方面加速了药物发现。然而,它们大多数都存在特征表示能力低的问题,这会显著影响预测性能。为了解决这个问题,我们提出了一种名为 DrugormerDTI 的新型神经网络架构,它使用图转换器通过输入分子图学习序列和拓扑信息,使用 Residual2vec 学习蛋白质中残基之间的潜在关系。通过进行消融实验,我们验证了 DrugormerDTI 中每个部分的重要性。我们还通过比较注意力层的映射结果和分子对接结果来证明我们模型的良好特征提取和表达能力。实验结果表明,我们提出的模型在四个基准测试中优于基线方法。我们证明了图转换器的引入和残基的设计对于药物-靶点预测是合适的。